21:10 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Bios provides BIOS Fund II update

Bios Partners (Fort Worth, Texas) said it has raised more than $21.3 million for its proposed BIOS Fund II. Bios told BioCentury that while $50 million is the fund's cap, the final figure is expected...
23:22 , Oct 11, 2017 |  BC Extra  |  Company News

Management tracks: Aerpio, Scancell, TCR2

Ophthalmic company Aerpio Pharmaceuticals Inc. (OTCQB:ARPO) named Stephen Hoffman CEO, effective Dec. 1, 2017. He succeeds Aerpio founder Joseph Gardner, who will remain its president. Hoffman was a senior advisor at PDL BioPharma Inc. (NASDAQ:PDLI),...
04:42 , Apr 7, 2017 |  BC Week In Review  |  Financial News

Azitra completes venture financing

Microbiome play Azitra Inc. (Farmington, Conn.) raised $2.9 million in a series A round led by Bios Partners on April 5. Azitra Inc. , Farmington, Conn. ...
21:33 , Dec 16, 2016 |  BioCentury  |  Emerging Company Profile

Floral delivery

Instability and poor penetration can make topical delivery of proteins and peptides into the skin inefficient and inconsistent. Azitra Inc. is using an engineered human commensal strain of bacteria to consistently deliver therapeutic proteins to...
07:00 , Oct 11, 2016 |  BC Extra  |  Financial News

Breakout Labs backs microbiome play Azitra

The Thiel Foundation 's Breakout Labs said it is providing funding to Azitra Inc. (Farmington, Conn.), a newco focused on using the skin microbiome to treat eczema and other skin diseases. The funds will support...